Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tekla Life Sciences Inves...

    NYSE: HQL · Real-Time Price · USD
    12.84
    0.03 (0.23%)
    At close: Jun 09, 2025, 3:59 PM
    12.80
    -0.27%
    After-hours: Jun 09, 2025, 04:09 PM EDT

    Tekla Life Sciences Investors Statistics

    Share Statistics

    Tekla Life Sciences Investors has - shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 33.54%

    Shares Floating

    n/a
    		 26.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 230

    FTD / Avg. Volume

    n/a
    		 0.19%

    Short Selling Information

    The latest short interest is 51.89K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 51.89K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 4.96 and the forward PE ratio is null. Tekla Life Sciences Investors's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 4.96

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 4.88

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.92

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Tekla Life Sciences Investors has an Enterprise Value (EV) of 423.17M.

    EV / Sales

    n/a
    		 4.88

    EV / EBITDA

    n/a
    		 0

    EV / EBIT

    n/a
    		 0

    EV / FCF

    n/a
    		 0

    Financial Position

    The company has a current ratio of 0.32, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.32

    Quick Ratio

    n/a
    		 0.32

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 18.56% and Return on Invested Capital is 18.01%.

    Return on Equity

    n/a
    		 18.56%

    Return on Assets

    n/a
    		 18.52%

    Return on Invested Capital

    n/a
    		 18.01%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0.19

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -7.19% in the last 52 weeks. The beta is 0.68, so Tekla Life Sciences Investors's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.68

    52-Week Price Change

    n/a
    		 -7.19%

    50-Day Moving Average

    n/a
    		 12.23

    200-Day Moving Average

    n/a
    		 13.75

    Relative Strength Index (RSI)

    n/a
    		 58.55

    Average Volume (20 Days)

    n/a
    		 119,269

    Income Statement

    In the last 12 months, Tekla Life Sciences Investors had revenue of 86.69M and earned 85.3M in profits. Earnings per share was 3.04.

    Revenue

    n/a
    		 86.69M

    Gross Profit

    n/a
    		 86.69M

    Operating Income

    n/a
    		 85.3M

    Net Income

    n/a
    		 85.3M

    EBITDA

    n/a
    		 n/a

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 3.04
    Full Income Statement

    Balance Sheet

    Cash & Cash Equivalents

    n/a
    		 n/a

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 44.13M

    Total Assets

    n/a
    		 460.58M

    Working Capital

    n/a
    		 -607K
    Full Balance Sheet

    Cash Flow

    Operating Cash Flow

    n/a
    		 n/a

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 n/a

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 98.4% and 98.4%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 98.4%

    Pretax Margin

    n/a
    		 98.4%

    Profit Margin

    n/a
    		 98.4%

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 98.4%

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    HQL pays an annual dividend of $2.37, which amounts to a dividend yield of 15.53%.

    Dividend Per Share

    n/a
    		 $2.37

    Dividend Yield

    n/a
    		 15.53%

    Dividend Growth (YoY)

    n/a
    		 20.51%

    Payout Ratio

    n/a
    		 77.96%

    Earnings Yield

    n/a
    		 20.16%

    FCF Yield

    n/a
    		 0%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HQL.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $15.2

    Lynch Upside

    n/a
    		 19.03%

    Graham Number

    n/a
    		 33.47

    Graham Upside

    n/a
    		 162.1%

    Scores

    Altman Z-Score

    n/a
    		 238.28

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist